STOCK TITAN

Zepp Clarity Introduces "Try Before You Buy" OTC Hearing Aids Program at CES 2025, Empowering Consumers with Confidence and Convenience

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Zepp Health (NYSE: ZEPP) has launched a 'Try Before You Buy' program for OTC hearing aids at CES 2025, addressing low adoption rates among adults with hearing loss. The initiative allows customers to test three models—Clarity Omni, Clarity One, and Clarity Pixie—in their homes before purchase.

The company introduced the Zepp Clarity Pixie, a next-generation hearing aid priced at $1,499, featuring a nearly invisible design, titanium alloy shell, IPX7 water resistance, and 17-hour battery life. The device includes Clarity Boost, Smart Phone Call support, and Find Device functionality, manageable through the Zepp Clarity App with eight customizable programs.

The program aims to tackle the low adoption rate of hearing aids, as only 15-30% of adults with mild-to-moderate hearing loss currently use them. All Zepp Clarity devices are FDA-Exempt Class II medical devices, targeting adults 18 and older, and come with lifetime customer support and certified audiologist access.

Zepp Health (NYSE: ZEPP) ha lanciato un programma 'Prova prima di comprare' per gli apparecchi acustici da banco al CES 2025, affrontando i bassi tassi di adozione tra gli adulti con perdita uditiva. L'iniziativa consente ai clienti di testare tre modelli—Clarity Omni, Clarity One e Clarity Pixie—nelle loro case prima di procedere all'acquisto.

L'azienda ha presentato il Zepp Clarity Pixie, un apparecchio acustico di nuova generazione al prezzo di 1.499 dollari, caratterizzato da un design quasi invisibile, una scocca in lega di titanio, resistenza all'acqua IPX7 e un'autonomia della batteria di 17 ore. Il dispositivo include Clarity Boost, supporto per le chiamate telefoniche e funzionalità di Trova dispositivo, gestibili tramite l'app Zepp Clarity con otto programmi personalizzabili.

Il programma mira a contrastare il basso tasso di adozione degli apparecchi acustici, poiché attualmente solo il 15-30% degli adulti con perdita uditiva da lieve a moderata li utilizza. Tutti i dispositivi Zepp Clarity sono dispositivi medici di Classe II esenti dalla FDA, destinati a adulti di 18 anni e oltre, e vengono forniti con supporto clienti a vita e accesso a un audiologo certificato.

Zepp Health (NYSE: ZEPP) ha lanzado un programa 'Prueba antes de comprar' para audífonos de venta libre en CES 2025, abordando las bajas tasas de adopción entre adultos con pérdida auditiva. La iniciativa permite a los clientes probar tres modelos—Clarity Omni, Clarity One y Clarity Pixie—en sus hogares antes de la compra.

La empresa presentó el Zepp Clarity Pixie, un audífono de nueva generación con un precio de 1.499 dólares, que presenta un diseño casi invisible, una carcasa de aleación de titanio, resistencia al agua IPX7 y una duración de batería de 17 horas. El dispositivo incluye Clarity Boost, soporte para llamadas telefónicas y funcionalidad de localización del dispositivo, gestionable a través de la app Zepp Clarity con ocho programas personalizables.

El programa tiene como objetivo abordar la baja tasa de adopción de audífonos, ya que solo el 15-30% de los adultos con pérdida auditiva leve a moderada los utiliza actualmente. Todos los dispositivos Zepp Clarity son dispositivos médicos de Clase II exentos de la FDA, dirigidos a adultos de 18 años o más, y vienen con soporte al cliente de por vida y acceso a un audiólogo certificado.

Zepp Health (NYSE: ZEPP)는 CES 2025에서 OTC 보청기를 위한 '구매 전 시도해보기' 프로그램을 시작하여 청력 손실이 있는 성인들 사이에서 낮은 채택률을 해결하고자 합니다. 이 프로그램은 고객이 Clarity Omni, Clarity One 및 Clarity Pixie 세 가지 모델을 구매하기 전에 자신의 집에서 테스트할 수 있도록 합니다.

회사는 1,499달러에 가격이 책정된 차세대 보청기 Zepp Clarity Pixie를 소개했으며, 거의 보이지 않는 디자인, 티타늄 합금 외장, IPX7 방수 기능, 17시간 배터리 수명을 특징으로 합니다. 이 장치는 Clarity Boost, 스마트폰 통화 지원 및 장치 찾기 기능을 포함하며, Zepp Clarity 앱을 통해 8개의 맞춤형 프로그램으로 관리할 수 있습니다.

이 프로그램은 현재 경증에서 중등도의 청력 손실이 있는 성인 중 15-30%만이 보청기를 사용하고 있는 낮은 채택률을 해결하는 것을 목표로 합니다. 모든 Zepp Clarity 장치는 FDA 면제 2등급 의료기기로, 18세 이상의 성인을 대상으로 하며, 평생 고객 지원 및 인증된 청각 전문가 접근권이 제공됩니다.

Zepp Health (NYSE: ZEPP) a lancé un programme 'Essayez avant d'acheter' pour les appareils auditifs en vente libre lors du CES 2025, afin de répondre aux faibles taux d'adoption chez les adultes souffrant de perte auditive. L'initiative permet aux clients de tester trois modèles—Clarity Omni, Clarity One et Clarity Pixie—dans leur domicile avant l'achat.

L'entreprise a présenté le Zepp Clarity Pixie, un aide auditif de nouvelle génération affiché au prix de 1 499 dollars, caractérisé par un design presque invisible, un boîtier en alliage de titane, une résistance à l'eau IPX7 et une autonomie de 17 heures. L'appareil inclut Clarity Boost, un support pour les appels téléphoniques et une fonctionnalité de recherche de l'appareil, gérable via l'application Zepp Clarity avec huit programmes personnalisables.

Le programme vise à combattre le faible taux d'adoption des appareils auditifs, car seuls 15 à 30 % des adultes souffrant de perte auditive légère à modérée les utilisent actuellement. Tous les dispositifs Zepp Clarity sont des dispositifs médicaux de Classe II exemptés de la FDA, destinés aux adultes de 18 ans et plus, et sont accompagnés d'un support client à vie et d'un accès à un audiologiste certifié.

Zepp Health (NYSE: ZEPP) hat im Rahmen der CES 2025 ein 'Probieren Sie, bevor Sie kaufen'-Programm für OTC-Hörgeräte gestartet, um die niedrigen Akzeptanzraten bei Erwachsenen mit Hörverlust anzugehen. Die Initiative ermöglicht es Kunden, drei Modelle—Clarity Omni, Clarity One und Clarity Pixie—zuhause vor dem Kauf zu testen.

Das Unternehmen stellte das Zepp Clarity Pixie vor, ein Hörgerät der nächsten Generation, das für 1.499 US-Dollar erhältlich ist und ein nahezu unsichtbares Design, ein Gehäuse aus Titanlegierung, IPX7-Wasserbeständigkeit und eine Akkulaufzeit von 17 Stunden bietet. Das Gerät verfügt über Clarity Boost, Unterstützung für Telefonate und die Funktion 'Gerät finden', die über die Zepp Clarity App mit acht anpassbaren Programmen verwaltet werden kann.

Das Programm zielt darauf ab, die niedrige Akzeptanzrate von Hörgeräten zu bekämpfen, da derzeit nur 15-30% der Erwachsenen mit leichten bis moderaten Hörverlust sie benutzen. Alle Zepp Clarity-Geräte sind von der FDA ausgenommene medizinische Geräte der Klasse II, die sich an Erwachsene ab 18 Jahren richten und mit lebenslangem Kundensupport sowie Zugang zu einem zertifizierten Audiologen geliefert werden.

Positive
  • Introduction of innovative 'Try Before You Buy' program reducing purchase barriers
  • Launch of advanced Clarity Pixie hearing aid with premium features
  • Lifetime customer support and certified audiologist access included
  • FDA-Exempt Class II medical device classification
Negative
  • High price point of $1,499 for Clarity Pixie model may limit market accessibility

Insights

The launch of Zepp Clarity's "Try Before You Buy" program represents an interesting but ultimately modest business development. While the OTC hearing aid market presents a $30 billion opportunity, with only 15-30% market penetration among potential users, several factors temper the immediate impact:

The $1,499 price point for the Pixie model positions it in the mid-range segment, competing against established players like Jabra and Sony. The lifetime support guarantee, while valuable, is standard in the industry. The 17-hour battery life and IPX7 rating meet but don't exceed category benchmarks.

The program addresses valid adoption barriers but faces significant challenges in customer acquisition and education costs. For a company with a $43.4M market cap, scaling customer support and audiologist networks requires substantial investment that could pressure margins.

The technical specifications of the Zepp Clarity lineup, particularly the Pixie model, align with current industry standards but don't represent a breakthrough innovation. The titanium alloy construction and IPX7 rating are positive features, but similar capabilities exist in competing products.

The Zepp Clarity App's eight customizable programs and features like Clarity Boost and Smart Phone Call support are table stakes in today's hearing aid market. While the Find Device feature adds convenience, it's not a differentiator in purchase decisions.

The wireless connectivity and app integration demonstrate competent engineering but don't provide a compelling technical advantage over existing solutions from major manufacturers.

MILPITAS, Calif., and LAS VEGAS, Jan. 6, 2025 /PRNewswire/ -- Zepp Clarity, the smart hearing solutions brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today unveiled its innovative "Try Before You Buy" program at CES 2025. This initiative addresses a critical gap in hearing aid adoption by encouraging the older population to explore hearing solutions in a low-pressure, hands-on environment.

Despite the widespread prevalence of disabling age-related hearing loss, industry surveys and epidemiological studies have consistently documented that only 15% to 30% of adults with mild-to-moderate hearing loss obtain hearing aids. Many cite uncertainty about their effectiveness or discomfort with the commitment as barriers to adoption.

The "Try Before You Buy" model empowers individuals to experience the transformative benefits of Zepp Clarity's advanced hearing solutions firsthand, boosting confidence and encouraging greater utilization of hearing aids.

With three state-of-the-art models—Clarity Omni, Clarity One, and Clarity Pixie — Zepp Clarity is redefining hearing care by offering consumers the opportunity to experience advanced hearing solutions through a trial period in their homes.

Zepp Clarity provides a lifetime customer support guarantee and access to certified audiologists to its users, ensuring professional guidance and peace of mind for every customer.

Zepp Clarity Pixie, A Nearly Invisible Hearing Aid Providing A Leap Forward in Technology

At the forefront of Zepp Clarity's offerings is the Zepp Clarity Pixie, a next-generation hearing aid solution designed for individuals with mild to moderate hearing impairment. The Pixie redefines the hearing aid experience with a nearly invisible design, seamless wireless connectivity, and a lightweight titanium alloy shell. Additional features include IPX7 water resistance, an impressive 17-hour battery life, and the ability to customize settings through the Zepp Clarity App, offering eight unique programs tailored to individual preferences.

The Pixie also includes innovative functionalities such as Clarity Boost, Smart Phone Call support, and a handy Find Device feature, ensuring users can navigate their daily routines with confidence and convenience. With a suggested retail price of $1,499, the Zepp Clarity Pixie is now available at https://clarity.zepp.com.

Empowering Hearing Health for All

Hearing loss impacts 48 million Americans and nearly 430 million people worldwide, yet adoption rates for hearing aids remain low. Zepp Clarity's mission is to address this critical health challenge by combining cutting-edge wearable technology with expert audiology insights.

Registered as FDA-Exempt Class II medical devices, Zepp Clarity's hearing aids are meticulously designed to offer discreet, high-performance solutions for adults aged 18 and older, enhancing both their hearing and overall wellness.

About Zepp Clarity

Zepp Clarity, a smart hearing solutions brand under Zepp Health, empowers individuals to live their healthiest lives. Guided by the belief that hearing health is integral to total wellness, Zepp Clarity leverages advanced hearable technologies, AI healthcare algorithms, and the expertise of leading audiologists to create personalized, high-performance hearing systems.

For more information about Zepp Clarity, visit https://clarity.zepp.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zepp-clarity-introduces-try-before-you-buy-otc-hearing-aids-program-at-ces-2025-empowering-consumers-with-confidence-and-convenience-302342231.html

SOURCE Zepp Health

FAQ

What is Zepp Health's new 'Try Before You Buy' program for hearing aids?

Zepp Health's 'Try Before You Buy' program allows customers to test their OTC hearing aids, including Clarity Omni, Clarity One, and Clarity Pixie models, in their homes before making a purchase decision.

How much does the Zepp Clarity Pixie hearing aid cost?

The Zepp Clarity Pixie hearing aid has a suggested retail price of $1,499.

What are the key features of ZEPP's Clarity Pixie hearing aid?

The Clarity Pixie features a nearly invisible design, titanium alloy shell, IPX7 water resistance, 17-hour battery life, Clarity Boost, Smart Phone Call support, Find Device feature, and eight customizable programs through the Zepp Clarity App.

What support does ZEPP provide with their hearing aids?

Zepp provides lifetime customer support and access to certified audiologists for all hearing aid users.

Are ZEPP Clarity hearing aids FDA approved?

Zepp Clarity hearing aids are registered as FDA-Exempt Class II medical devices for adults aged 18 and older.

Zepp Health Corporation American depositary shares, each representing sixteen

NYSE:ZEPP

ZEPP Rankings

ZEPP Latest News

ZEPP Stock Data

44.02M
6.87M
5.76%
43.45%
0.17%
Consumer Electronics
Technology
Link
United States of America
Hefei